Banneker Ventures Awarded Design-Build Contract to Build Nuclear Magnetic Resonance Laboratory at FDA’s Headquarters Campus

Banneker Ventures announced today that it has been awarded a design-build contract to build a Nuclear Magnetic Resonance (“NMR”) Laboratory Suite at the U.S. Food and Drug Administration’s (“FDA”) new Consolidated Headquarters campus in White Oak, Maryland.   This two-phase project includes the installation of a Nitrogen-base fire suppression system in half a dozen laboratories on FDA’s White Oak campus as well as the design-build construction of one of the largest NMR Suites on the East Coast of the Untied States.  

Omar Karim, Banneker’s President, remarked that “Banneker is grateful to have the opportunity to work with the U.S. General Services Administration and the U.S. Food and Drug Administration on this high profile and complex laboratory project.   The team that we have assembled include some of the most experienced laboratory contractors in the industry.”  

Banneker has hired LSY Architects, one of the nation’s leading laboratory design firms, to lead the design efforts of the NMR Suite and Suppression Systems, Inc., the premier fire protection company serving the Northeast region of the United States to design and install the fire suppression system in the laboratories.  

Banneker Ventures is a full-service construction and facilities management company with offices in Maryland and Washington, DC.   An SBA certified 8(a) small business, Banneker provides value added services to government agencies, quasi-government agencies and commercial clients.